Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV002171654 | SCV002479912 | likely benign | not provided | 2023-11-22 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002427712 | SCV002740602 | likely benign | Cardiovascular phenotype | 2020-03-24 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
New York Genome Center | RCV003228056 | SCV003925358 | uncertain significance | Hypoalphalipoproteinemia, primary, 1; Tangier disease | 2022-04-15 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003331325 | SCV004038423 | uncertain significance | not specified | 2023-08-01 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004543904 | SCV004766261 | likely benign | ABCA1-related disorder | 2019-12-11 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |